compound semaglutide fda GLP-1 Weight Loss- Compounded – Lolachi Institute FDA Warns Against Using Compounded

FDA notes that compounded drugs should generally be used only when a patients medical needs cannot be met by an FDA-approved drug or during recognized shortages, and that compounded GLP-1 products may carry additional risksincluding dosing errors or contaminationbecause they have not been evaluated for safety, effectiveness, or quality

Why Consider a Weight Loss Medication

While patches are promising, its important to note that GLP-1 patches are still emerging in clinical trials and are not as widely available as injections

doi: 10.3389/fendo.2021.678055

These lab tests verify four key characteristics related to quality and safety: Potency test Passed Sterility test Passed pH test Passed Endotoxicity Passed Your questions answered Still have questions

Others successfully maintain weight loss through lifestyle alone